secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001493152-23-040500
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Q3 revenue surges 314% to $974,894; clinics generate positive net income; merger with NAYA pending
--------------------------------------------------------------------------------

- Revenue $974,894 (+314% YoY); pro forma revenue incl. full WFI quarter ~$1.5M (+534%).
- Net loss $(1.2)M improved from $(2.5)M; pro forma net loss $(1.0)M.
- Adjusted EBITDA $(0.6)M vs $(2.0)M; pro forma $(0.3)M; clinics profitable excluding corporate overhead.
- Cash & equivalents $1.1M as of Sep 30, 2023.
- Merger with NAYA Biosciences (all-stock) - closing conditions including shareholder approval and $5M+ PIPE not yet satisfied.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223040500/0001493152-23-040500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315223040500/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-040500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer